Decoding Your Body: How Overall and Abdominal Fat Impact Blood Viscosity
"Unraveling the separate mechanisms by which different types of fat affect your health – and what it means for you."
Recent studies have highlighted a concerning link between both general and abdominal obesity and an increased risk of mortality. This has led to a greater emphasis on using measurements like waist circumference and waist-to-hip ratio (WHR) in addition to body mass index (BMI) to assess health risks. However, the question of whether BMI fully accounts for the obesity-related risks, particularly for conditions like diabetes and coronary heart disease (CHD), remains a subject of debate.
To investigate the distinct impacts of overall adiposity (BMI) and abdominal adiposity (WHR) on blood flow properties (rheology), researchers analyzed data from 430 patients. This group represented a wide range of ages (11-77 years) and BMIs (15-50 kg/m²), offering a comprehensive view of how different body compositions affect blood viscosity.
The study aimed to determine how BMI and WHR independently influence blood viscosity, going beyond simply noting correlations. The researchers sought to understand the underlying mechanisms by which different types of fat might impact cardiovascular health. This information can help individuals better understand their own risk factors and take proactive steps toward wellness.
Body Fat and Blood Viscosity
A forward stepwise regression selected waist-to-hip ratio (WHR) as a better predictor of blood viscosity than body mass index (BMI), excluding BMI from the model. Research published June 1, 2025, reported that blood viscosity was affected by abdominal adiposity, whole-body fat mass, and fat-free-mass gain. The measurement of visceral fat is clinically important for identifying people at high risk of visceral-obesity-related health conditions.
Measuring Fat and Viscosity
Body-composition methods involve trade-offs among accuracy, cost, participant burden, portability, and the ability to measure specific body compartments. A 2019 meta-analysis evaluated alternative methods for quantifying intra-abdominal adipose tissue against computed tomography (CT) and magnetic resonance imaging (MRI), which served as reference standards. A 2025 review similarly emphasized that newer technologies each have distinct benefits and limitations, so no single method is ideal for every purpose.
Early Rheology Evidence
A 2016 evaluation examined associations between different adiposity indices and blood viscosity. It used a microchannel method to assess blood rheological properties. The source reports that this method reflects blood viscosity and the state of microthrombus formation, which may help predict cardiovascular thrombotic events.
BMI vs. WHR: Unpacking the Separate Effects on Blood Viscosity
The study confirmed that BMI and WHR are correlated, meaning that higher overall body fat often accompanies higher abdominal fat. Both BMI and WHR were found to be predictors of blood viscosity, suggesting that both overall and abdominal fat contribute to thicker blood.
- BMI's effect on blood viscosity is linked to its correlation with plasma viscosity (the thickness of the liquid portion of blood) and red blood cell (RBC) aggregation (how easily RBCs clump together).
- WHR's effect is strongly tied to hematocrit, which is the percentage of red blood cells in the blood. Higher abdominal fat was associated with higher hematocrit, but not with plasma viscosity or RBC aggregation.
Distinct Adiposity Associations
A review reports that overall adiposity is associated with increased red-cell aggregation, while abdominal adiposity is associated with increased hematocrit. It also links overall BMI with increased plasma viscosity and red-cell rigidity, factors that increase whole-blood viscosity. A 2025 study noted that reported viscosity changes vary according to waist circumference, waist-to-hip ratio, and BMI, while a 2026 systematic review described blood viscosity as a biomarker of hematological, cardiovascular, and inflammatory conditions.
Correlation Is Not One Mechanism
The source titled “Both overall adiposity and abdominal adiposity increase blood viscosity by separate mechanisms” cautions that correlations with determinants of viscosity do not all have the same meaning. This challenges interpretations that treat BMI and abdominal-fat measures as interchangeable explanations for hyperviscosity. The key limitation is therefore mechanistic: similar associations with viscosity may reflect different underlying pathways.
Visceral Fat and Metabolic Risk
A 2024 comparison of visceral-adipose-tissue measurement methods describes excessive adipose tissue, particularly visceral abdominal fat, as closely related to several aspects of metabolic syndrome. The source specifically names hypertension, dyslipidemia, and diabetes as examples. It also notes increasing prevalence of obesity and other metabolic syndromes in the general population.
What Does This Mean for You? Key Takeaways
This research underscores the importance of considering both overall body fat and abdominal fat when assessing cardiovascular risk. While BMI provides a general measure of weight, WHR offers a more specific indication of fat distribution, which appears to have a unique influence on blood viscosity.
Why Fat Distribution Matters
BMI does not account for body-fat and lean-mass distribution, which can affect health risks differently. Both abdominal subcutaneous adipose tissue and visceral adipose tissue are associated with increased morbidity, but the association is stronger for visceral adipose tissue. A 2025 report adds that abdominal fat is considered particularly dangerous because obesity can remodel blood vessels in ways that promote inflammation and functional disorders.
Two Paths to Hyperviscosity
The source reports that both BMI and waist-to-hip ratio are associated with increased blood viscosity. However, the correlations reflect separate mechanisms, indicating that overall adiposity and abdominal adiposity should not be treated as identical risk markers. It concludes that both forms of adiposity induce hyperviscosity, consistent with epidemiological links between coronary heart disease risk, abdominal adiposity, and BMI.
The finding that abdominal fat is linked to increased hematocrit suggests a possible mechanism by which it raises cardiovascular risk. Higher hematocrit can lead to thicker blood, making it harder for the heart to pump and increasing the likelihood of clots.
Ultimately, these findings support the idea that reducing both overall and abdominal fat is crucial for maintaining healthy blood flow and reducing the risk of heart disease. Focusing on a healthy lifestyle that includes a balanced diet and regular exercise can help manage both BMI and WHR, contributing to improved cardiovascular health.